Biomarker Profiles Corporation was developed on the idea of making biomarker discovery more efficient by breaking the discovery process into different components and developing each component separately. The idea was born while attending attending a biorepository meeting sponsored by the National Cancer Institute in 2007. The idea evolved. Biomarker Profiles Corporation was incorporated in the state of Delaware in 2010. Qualified to do business in California in February 2011. Opened for business in April 2011.
Our founder, Dr. Leticia Cano, became a mass spectrometry expert while working as a MALDI-TOF Application Scientist at Bruker Daltonics. Her expertise are in the areas of mass spectrometry analysis (peptides, proteins, polymers), peptide fragmentation, and automation. She went back to school and obtained a PhD. For her PhD dissertation, she identified the native citrullinated fibrinogen epitope in Rheumatoid Arthritis. Her expertise developed in the areas of protein separations, proteomics, protein tagging, protein arrays, ELISA development and translational research. Dr. Cano did her postdoctoral work at the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) in the laboratory of Hank Fales and identified candidate biomarkers in four autoimmune diseases (dermatomyositis, systemic lupus erythematosus and juvenile idiopathic arthritis). Her interests developed in the areas of bioinformatics, biorepositories and bioethics. Dr. Cano founded Latina Scientist, a free networking group. For fun, she enjoys recreational shooting with her “baby” revolver.
We love our customers and welcome your feedback and suggestions. Use our Contact Us page to tell us what we’re doing right or what we can improve on.